Asia Healthcare Holdings takes majority stake in Asian Institute of Nephrology and Urology
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
The products will be manufactured at the company's facility in Bengaluru
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Subscribe To Our Newsletter & Stay Updated